NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most fatal type of breast cancer (BC). Due to the lack of relevant targeted drug therapy, in addition to surgery, chemotherapy is still the most common treatment option for TNBC. TNBC is heterogeneous, and different patients have an unusual sensitivity to...

Full description

Bibliographic Details
Main Authors: Xiangming He, Jinping Gu, Dehong Zou, Hongjian Yang, Yongfang Zhang, Yuqing Ding, Lisong Teng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Molecular Biosciences
Subjects:
metabolomics
triple-negative breast cancer
metabolic pathway
ROC curve
NMR spectroscopy
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.708052/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.708052/full

Similar Items